is mounjaro a semaglutide or tirzepatide (Mounjaro Generic) Understanding the Differences Between Mounjaro

GLP-1 drugsinitially designed to help treat type 2 diabetes by triggering insulin releasecan cause weight loss by making people feel full faster

Discontinuing GLP-1 receptor agonists typically leads to reversal of their therapeutic effects , though the timeline and extent vary between individuals

Tirzepatide and other GLP-1 agonists can impair B12 absorption over time

The hormone-aware GLP-1 prescribing model, lab testing, and dietitian access set a high clinical bar

Individual response timelines vary

GLP-1 remains the backbone, but layering complementary signals from GIP, glucagon, amylin and PYY allows for unprecedented degrees of weight reduction and metabolic restoration, as summarised for comparison in Table 1